Medicinal chemistry – Page 37
-
Article
Why biocatalysis is so on trend
Biocatalysis has come a long way from just beer – there’s an enzyme for nearly everything
-
Article
The ever-increasing attraction of biologics
Biologics promise targeted treatments for a range of conditions – if we can overcome the technological challenges
-
Feature
The chemistry of the microbiome
Our gut bacteria are carrying out chemistry on our behalf, but without us knowing much about it. Now, scientists are starting to examine their enzymes
-
Feature
The antibiotic countdown
Where are the next generation of antibiotics going to come from? Clare Sansom looks at the pipeline
-
Research
Antimalarial plant's chlorophyll catalyses drug synthesis
New ‘green’ method makes malaria-fighting artemisinin’s synthesis faster and cheaper with industrial production planned for 2021
-
News
Tracker to name and shame for failure to report clinical trial results
Developers of online tool hope that it will improve accountability
-
News
FDA approves new way to make medical imaging isotope
System will be the US’s first domestic source of molybdenum-99 for 30 years
-
Business
BMS stimulates cancer drug hopes with giant collaboration
Immunooncology pioneer will pay up to $3.6bn in hope Nektar drug will help non-responders
-
News
Illegal antibiotic combinations threaten efforts to battle antimicrobial resistance
Unapproved formulations make up two-thirds of combination therapies sold in India
-
Feature
Artificial blood
Nina Notman reports on progress towards products that can, when necessary, replace donor red blood cells
-
Research
Antibiotic analogue puts researchers on path to ending herbicide drought
Research flags DNA gyrase as a new target for pesticides
-
Research
Soil search unearths new class of antibiotics
Malacidins have a novel mode of action and can kill MRSA
-
Review
Venom: killer and cure
Emma Stoye reviews a celebration of toxic critters large and small at London’s Natural History Museum
-
Business
Celgene takes a punt on M&A
Cancer specialist bags Juno therapeutics and Impact Biomedicines
-
Business
FDA new drug approvals more than doubled in 2017
The FDA approved 46 new drugs last year – the highest number in over two decades – due to factors like streamlined policies at the agency
-
Research
Deadly component of centipede venom identified
Neurotoxin allows poisonous predator to subdue a mouse within half a minute
-
News
Changing political climate threatens US cannabis research
Trump administration reverses rule protecting states with legalised marijuana
-
Business
Dementia slips down pharma agenda
Pfizer, Shire, Acorda and Axovant rethink their neuroscience strategies
-
Research
Natural and unnatural peptides team up to target Ebola
New method to hunt down protease-stabilised peptide inhibitors of large proteins
-
Research
Nicotine degrading enzyme could help smokers quit
Enzyme removes nicotine from blood before it can stimulate brain’s reward system